Seattle Genetics | SGEN - Stock


Seattle Genetics reported $531.19M in Stock for its fiscal quarter ending in September of 2023.



Stock Change Date
AbbVie USD 4.95B 13M Dec/2025
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
Agios Pharmaceuticals USD 32.92M 886K Dec/2025
Amgen USD 6.22B 121M Dec/2025
Astellas Pharma JPY 297.26B 9.92B Mar/2025
Bayer EUR 12.33B 221M Sep/2025
Biogen USD 2.17B 41.3M Dec/2025
BioMarin Pharmaceutical USD 1.3B 83.29M Dec/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Daiichi Sankyo JPY 608.55B 93.64B Sep/2025
Eisai JPY 236.46B 9.14B Sep/2025
Eli Lilly USD 13.74B 1.56B Dec/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Exelixis USD 27.4M 3.92M Sep/2025
Genmab DKK 13M 1000K Jun/2025
Gilead Sciences USD 1.78B 40M Sep/2025
GlaxoSmithKline GBP 6.12B 46M Sep/2025
Glaxosmithkline GBP 6.12B 46M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
Insmed USD 132.07M 11.1M Dec/2025
Karyopharm Therapeutics USD 4.04M 72K Dec/2025
MacroGenics USD 7.91M 840K Dec/2025
Merck USD 6.44B 157M Sep/2025
Moderna USD 332M 92M Sep/2025
Nektar Therapeutics USD 14.46M 1.78M Jun/2024
Novartis USD 6.42B 114M Sep/2025
Pfizer USD 11.47B 201M Sep/2025
Puma Biotechnology USD 9.48M 885K Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sanofi EUR 22.69B 1.81B Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Takeda JPY 1.41T 107.71B Dec/2025
Teva Pharmaceutical Industries USD 3.18B 144M Dec/2025
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025